897369-18-5

897369-18-5 structure
897369-18-5 structure
  • Name: BCR-ABL-IN-2
  • Chemical Name: BCR-ABL-IN-2
  • CAS Number: 897369-18-5
  • Molecular Formula: C24H25Cl2N5O3
  • Molecular Weight: 502.39
  • Catalog: Signaling Pathways Protein Tyrosine Kinase/RTK Bcr-Abl
  • Create Date: 2019-02-12 06:03:16
  • Modify Date: 2024-01-10 16:25:52
  • BCR-ABL-IN-2 is an inhibitor of BCR-ABL1 tyrosine kinase, with IC50s of 57 nM, 773 nm for ABL1native and ABL1T315I, respectively.

Name BCR-ABL-IN-2
Description BCR-ABL-IN-2 is an inhibitor of BCR-ABL1 tyrosine kinase, with IC50s of 57 nM, 773 nm for ABL1native and ABL1T315I, respectively.
Related Catalog
Target

ABL1native:57 nM (IC50)

ABL1T315I:773 nM (IC50)

In Vitro BCR-ABL-IN-2 (Compound 1) contains a urea moiety to allow a hydrogen bond with the conserved K271-E286 salt bridge of ABL1, a t-butyl moiety to bind into the hydrophobic spine at the third pocket position, and a 2,3-dichlorophenyl ring to stabilize the DFG-phenylalanine F382 in the Type II-out conformation. BCR-ABL-IN-2 exhibits an IC50 of 57 nM for ABL1native and an IC50 of 773 nM for ABL1T315I[1]. Despite ABL, BCR-ABL-IN-2 can also inhibit KDR, BRaf, p38 kinase with IC50s of 1.8 μM, 0.23 μM, 6.3 nM, 43 nM, respectively[2].
References

[1]. Chan WW, et al. Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036. Cancer Cell. 2011 Apr 12;19(4):556-68.

[2]. ARYL SULFONOHYDRAZIDES. US 2008/0113967 A1.

Molecular Formula C24H25Cl2N5O3
Molecular Weight 502.39